Hepatitis B virus (HBV) coinfection accelerates immunologic progression in patients with primary HIV infection in an area of hyperendemicity for HBV infection

Journal of Infectious Diseases

Volumn 208, Issue 7, 2013, Pages 1184-1186

  Tsai, Mao Song ^a   Chang, Sui Yuan ^a,b   Lo, Yi Chun ^c   Yang, Chia Jui ^d   Sun, Hsin Yun ^a   Liu, Wen Chun ^a   Wu, Pei Ying ^a   Hung, Chien Ching ^a,e,f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b National Taiwan University College of Medicine ^*  (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; ENDEMIC DISEASE; GENOTYPE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MIXED INFECTION; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; TAIWAN; VIRAL TROPISM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; FEMALE; MALE; NOTE; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COINFECTION; DISEASE PROGRESSION; FEMALE; HEPATITIS B, CHRONIC; HIV SEROPOSITIVITY; HUMANS; MALE;

EID: 84887289813     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit299     Document Type: Letter

References (8)

1. Chun HM, Roediger MP, Hullsiek KH, et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis 2012; 205:185-93
2. Sun HY, Ko WC, Tsai JJ, et al. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009; 104:877-84
3. Skrabal K, Low AJ, DongW, et al. Determining human immunodeficiency virus coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model. J Clin Microbiol 2007; 45: 279-84
4. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A: D study. Arch Intern Med 2006; 166:1632-41
5. Sheng WH, Kao JH, Chen PJ, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007; 45:1221-9
6. Peters PJ, Marston BJ. Preventing deaths in persons with HIV/hepatitis B virus coinfection: A call to accelerate prevention and treatment efforts. J Infect Dis 2012; 205: 166-8
7. Ni YH, Chang MH, Wu JF, Hsu HY, Chen HLChen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012; 57:730-5
8. Department of Health and Human Services; Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/Content Files/AdultandAdolescentGL.pdf. Accessed 30 December 2012